Bone Biologics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -1,392 | 48 | -748 | -1,017 |
EBIT | -677 | -666 | -748 | -1,038 |
Net Income | -684 | -666 | -740 | -1,017 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -714 | -591 | -458 | -926 |
Cash | 5,334 | 6,049 | 6,640 | 2,746 |
Basic Shares | 1,174 | 1,795 | 557 | 3,183 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | ||
EBITDA | -3,108 | 107 | 479 | -752 |
EBIT | -4,112 | -8,948 | -8,062 | |
Net Income | -3,108 | -4,112 | -8,949 | -1,484 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,691 | -4,124 | -9,555 | -3,566 |
Cash | 5,334 | 3,325 | 3,026 | 7,538 |
Basic Shares | 1,174 | 1,517 | 263 | 47 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.63 |
2025-09-30 | -$0.37 |
2025-06-30 | -$1.33 |
2025-03-31 | -$0.31 |
